Antihistamine agent dimebon as a novel neuroprotector and a cognition enhancer

Annals of the New York Academy of Sciences

Volumn 939, Issue , 2001, Pages 425-435

  Bachurin, S ^a   Bukatina, E ^a   Lermontova, N ^a   Tkachenko, S ^a   Afanasiev, A ^a   Grigoriev, V ^a   Grigorieva, I ^a   Ivanov, Yu ^a   Sablin, Sergey ^b,c   Zefirov, N ^a  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^b Selena Pharmaceuticals Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Cognition enhancer; Dimebon; Neuroprotector

Indexed keywords

AMYLOID BETA PROTEIN; ANTIHISTAMINIC AGENT; CHOLINESTERASE; DIMEBON; ETHYLCHOLINE MUSTARD AZIRIDINIUM; NEUROPROTECTIVE AGENT;

ADULT; ALZHEIMER DISEASE; CHOLINERGIC NERVE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; MALE; MEMORY; NEUROPROTECTION; PERSONALITY; PSYCHOLOGIC TEST; TREATMENT OUTCOME;

EID: 0034944798     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03654.x     Document Type: Conference Paper

References (23)

1. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: Relevance to Alzheimer's disease
2. 2+ influx in cultured hippocampal neurons
3. Neuron-specific and state-specific differences in calcium homeostasis regulate the generation and degeneration of neuronal architecture
4. 2+ and other second messengers in excitatory amino acid receptor mediated neurodegeneration: Clinical perspectives
5. Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia
6. Psychogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy
7. Low affinity use-dependent NMDA receptor antagonists show promise for clinical development
8. Pharmacol
9. Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells: Role of the glutamate receptor responsive to N-methyl-D-aspartate
10. Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity
11. Effects of tacrine on deficits in active avoidance performance induced by AF64A in rats
12. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ASRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
13. Effects of intrahippocampal injections of the cholinergic neurotoxin AF64A on open-field activity and avoidance learning in the rat
14. Effects of physostigmine on AF64A-induced impairment of learning acquisition in rats
15. The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain
16. Action of Dimebon on histamine receptors
17. Neuromediator mechanisms of the effect of the antihistamine agent Dimebon on the brain
18. Preclinical study of the safety of the antihistaminic preparation Dimebon
19. Evaluation of the effect of the antihistaminic preparations Dimebon and diprazin on embryogenesis in rats
20. Comparative evaluation of the anti-arrhythmia efficacy of fencarol and Dimebon during neurogenic atrial fibrillation
21. Comparative evaluation of the effect of Dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction
22. Effect of Dimebon on coronary blood flow and myocardial contractibility